Jeffrey T. Kirby

Antimicrobial Susceptibility and Epidemiology of a Worldwide Collection of <i>Chryseobacterium</i> spp.: Report from the SENTRY Antimicrobial Surveillance Program (1997-2001)

Jeffrey T. Kirby, Hélio S. Sader, Timothy R. Walsh et al. · Journal of Clinical Microbiology · 2004 · 280 citations · Full text

Geographic variations in activity of broad-spectrum β-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997–2000)

Ronald N. Jones, Jeffrey T. Kirby, Mondell L. Beach et al. · Diagnostic Microbiology and Infectious Disease · 2002 · 90 citations

Antimicrobial Susceptibility, Health Sciences, Antibiotics +13

Activity of Contemporary Antifungal Agents, Including the Novel Echinocandin Anidulafungin, Tested against <i>Candida</i> spp., <i>Cryptococcus</i> spp., and <i>Aspergillus</i> spp.: Report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007)

S. A. Messer, Gary J. Moet, Jeffrey T. Kirby et al. · Journal of Clinical Microbiology · 2009 · 75 citations · Full text

Fungal Diversity, Antifungal Agent, Antibiotics +15

In vitro activity of tigecycline (GAR-936) tested against 11,859 recent clinical isolates associated with community-acquired respiratory tract and gram-positive cutaneous infections

Thomas R. Fritsche, Jeffrey T. Kirby, Ronald N. Jones · Diagnostic Microbiology and Infectious Disease · 2004 · 75 citations

Gram-positive Cutaneous Infections, Medicine, Recent Clinical Isolates +4

Comparative activity of meropenem in US medical centers (2007): initiating the 2nd decade of MYSTIC program surveillance

Ronald N. Jones, Jeffrey T. Kirby, Paul R. Rhomberg · Diagnostic Microbiology and Infectious Disease · 2008 · 59 citations

Health Administration, Primary Care, Comparative Activity +8